Case Control Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 26, 2023; 11(24): 5643-5652
Published online Aug 26, 2023. doi: 10.12998/wjcc.v11.i24.5643
Table 2 Univariate analysis of progression-free survival and overall survival
Prognostic factorPFS
OS
HR (95%CI)
P value
HR (95%CI)
P value
Age (yr)1.051 (1.031-1.071)≤ 0.0011.034 (1.012-1.055)0.002
Gender1.265 (0.828-1.931)0.2771.412 (0.926-2.152)0.109
Classification1.037 (0.949-1.132)1.0371.093 (0.999-1.196)0.053
ISS stage1.718 (1.247-2.366)0.0012.093 (1.520-2.883)≤ 0.001
DS stage2.094 (1.082-4.054)0.0281.982 (1.015-3.869)0.045
GPT1.011 (1.002-1.021)0.0191.009 (0.999-1.019)0.082
GOT1.022 (1.011-1.033)≤ 0.0011.025 (1.013-1.038)≤ 0.001
CRP1.002 (0.996-1.007)0.5931.002 (0.996-1.008)0.491
A/G1.041 (0.698-1.553)0.8441.149 (0.754-1.751)0.518
LDH1.003 (1.001-1.004)≤ 0.0011.003 (1.002-1.005)≤ 0.001
t(6;14)1.021 (0.319-3.266)0.9721.285 (0.399-4.134)0.674
t(11;14)1.149 (0.281-4.708)0.8471.188 (0.290-4.871)0.811
Platelet count9.604 (4.965-18.578)≤ 0.0018.437 (4.528-15.721)≤ 0.001
Herpes0.821 (0.451-1.495)0.520.908 (0.498-1.653)0.751
Chemotherapy regimen1.005 (0.856-1.180)0.9520.949 (0.795-1.133)0.564
Autotransplantation0.339 (0.137-0.842)0.0200.347 (0.140-0.860)0.022
TC0.773 (0.631-0.947)0.0130.757 (0.617-0.927)0.007
TG0.861 (0.666-1.114)0.2550.846 (0.642-1.113)0.232
P1.143 (0.953-1.370)0.151.113 (0.934-1.325)0.232
C1 reduction rate0.412 (0.325-0.521)≤ 0.0010.438 (0.346-0.554)≤ 0.001
C2 reduction rate0.412 (0.325-0.523)≤ 0.0010.441 (0.351-0.553)≤ 0.001
C3 reduction rate0.390 (0.303-0.501)≤ 0.0010.377 (0.290-0.490)≤ 0.001
C4 reduction rate0.358 (0.283-0.455)≤ 0.0010.345 (0.267-0.445)≤ 0.001